Bomi Technology showcases multiple image testing equipment at CIOE China Light Expo
At the CIOE exhibition, Bomi Technology showcased its accumulation in image quality testing in the field of camera technology and applications, showcasing products such as multispectral light boxes, endoscopic testing system BOMI-TSECIT, and standard QC light box BM03QC.From October 30th to November 1st, 2025, the American company Proveris Science and the Chinese distributor Shanghai Liangtong Industrial Co., Ltd. hosted the 2nd Proveris China User Training Conference in Nanjing and participated in the 4th International Symposium on Inhalation Drug Delivery hosted by the Chinese Particle Society.
The 2nd Proveris China User Training and Exchange Conference
On October 30th, more than 30 experts and teachers from the industry gathered in Nanjing to participate in this user training and exchange meeting.

During the conference, experts and teachers from Proveris Scientific, Shangyao Xinyi, and Apta Pharmaceuticals gathered aroundUSPSpecial presentations were made on regulations, testing services, in vitro performance research, and other related topics; Subsequently, the Vice President and Product Manager of Proveris provided detailed answers to users' actual usage issues. The interactive questioning session had a lively atmosphere and enthusiastic feedback.






International Symposium on Inhalation Drug Delivery in 2025
The 4th International Symposium on Inhalation Drug Delivery (IDDA) was held from October 31st to November 1st, attracting over 300 industry professionals and experts from home and abroad to participate. Shanghai Liangtong Industrial Co., Ltd. represents the United StatesProveris Science Company set up an exhibition at the conference site and actively communicated and discussed with the attending guests.






On the morning of November 1st, Ben Okorodudu, Vice President of ProverisA speech titled "From Regulations to Results: Best Practices for Uniformity of Delivery Dose in Nasal Spray and Aerosol Products" was delivered at the conference, detailing the latest FDA regulations' requirements for uniformity of delivery dose.

This trip to Nanjing not only gained new insights and stimulated more thinking, but also further strengthened our connections with customers and partners. Thank you to every participant for their support and enthusiasm. Looking forward to reuniting with everyone in future events!












